Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hinge HealthHNGE -5.92%12 EV-to-EBITDA is 67.74 as of Aug. 30, 2026. GuruFocus rates HNGE with a GF Score™ of 12/100. The stock has 7 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Hinge Health ranks worse than 94.56% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hinge Health's enterprise value is $6,665.2 Mil.
Hinge Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $98.4 Mil. Therefore, Hinge Health's EV-to-EBITDA for today is 67.74.
The historical rank and industry rank for Hinge Health's EV-to-EBITDA or its related term are showing as below:
HNGE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.25 Med: -5.45 Max: 214.05
Current: 67.74
During the past 3 years, the highest EV-to-EBITDA of Hinge Health was 214.05. The lowest was -12.25. And the median was -5.45.
HNGE's EV-to-EBITDA is ranked worse than 94.56% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs HNGE: 67.74
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hinge Health's PE Ratio (TTM) for today is calculated as:
Hinge Health's share price for today is $87.35.
Hinge Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Hinge Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Hinge Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hinge Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hinge Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hinge Health's EV-to-EBITDA falls into.
Hinge Health's current Enterprise Value is $6,665.2 Mil.
Hinge Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $98.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hinge Health (HNGE) has a EV-to-EBITDA of 67.74 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hinge Health. According to the industry distribution chart, Hinge Health ranks #487 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 94.6%.
Is Hinge Health's EV-to-EBITDA too high?
Hinge Health's current EV-to-EBITDA is 67.74. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.62. Hinge Health's value of 67.74 is 537.9% above this industry median. Based on the distribution chart, Hinge Health ranks #487 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hinge Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hinge Health's EV-to-EBITDA compare to TXG and WAY?
According to the Healthcare Providers & Services industry distribution chart, Hinge Health ranks #487 out of 515 companies for EV-to-EBITDA. This places Hinge Health in the lower half of its industry. The industry median EV-to-EBITDA is 10.62. Hinge Health's value of 67.74 is 537.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.62, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hinge Health's current EV-to-EBITDA of 67.74 is 537.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hinge Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hinge Health's current EV-to-EBITDA is 67.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hinge Health stock overvalued right now?
Hinge Health (HNGE) has a current EV-to-EBITDA of 67.74. The current EV-to-EBITDA is 67.74 and 537.9% above the Healthcare Providers & Services industry median of 10.62. Hinge Health's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Hinge Health (HNGE), the current EV-to-EBITDA is 67.74 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
12GF Score
Get the complete analysis for HNGE
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNGE has been successfully added to your 
